Emerging Mechanisms in Obesity: NLRP3 inhibiton doesn’t move the scale
This past month, I have been immersed in obesity science, and one thing’s clear: not every pathway moves the scales. After dissecting […]
Category: Therapy Area Deep Dive
Its all to play for in the next generation of obesity treatments – Viking Therapeutics
It has been a quiet summer on the post front with holidays and then a few active projects keeping us very but, […]
What is Happening in Pain: The Next Wave of Sodium Channel Blockers
Intro At the end of May, Eli Lilly announced a $1 billion deal with Site One Therapeutics, a company developing a Nav1.8 […]